Effectiveness comparison of physiotherapy with balance and gait exercises and physical therapy with strengthening exercises in patients with Parkinson's disease

Not Applicable

• Conditions: Parkinson disease; C10.228.140.079.862.500

• Registration Number: RBR-3p7zcf
• Lead Sponsor: niversidade Estadual de Londrina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Medical diagnosis of Parkinson's disease, according to the criteria of the London Brain Bank (Uk Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria): First step: Bradykinesia associated with at least one of the following symptoms: resting tremor, muscle stiffness or alteration of postular reflexes; Second stage: diagnostic exclusion criteria; Lack of clinical signs of secondary forms of parkinsonism or parkinsonism; No change in eye movements, dementia in the first year of symptoms, cerebellar ataxia, severe dysautonomia, falls and serious imbalance in the first year of symptoms, etc. Third stage: Criteria for diagnoses support; Home unilateral and asymmetrical course;
The first side is affected the most committed throughout evolution; Presence of resting tremor; Progression of symptoms;
Excellent response to levodopa; Response to levodopa lasting five or more years; Levodopa-induced dyskinesia; Clinical course of ten years or more. Individuals over 50 years. Do not institutionalized. Mini Mental score at least that does not characterize cognitive impairment. Hohen Yahr 1.5 to 3.0. What part of the project accept and sign the consent according term to the criteria of the Ethics Committee of the Universidade Estadual de Londrina, according to the parecer 466/2912 (CNS).

Exclusion Criteria

Individuals who perform other therapeutic treatment beyond drug that has change in medication during the study or those with associated diseases, such as neurological disorders, severe heart disease, amputations, cognitive deficits or understanding. Change in the stabilization of the antiparkinsonian doses throughout the study.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improve balance verified by the force BIOMEC 400 platform (EMG System of Brazil) between pre- and post-intervention variables: amplitude (Hz), velocity (centimeters/second) and the center of pressure of the feet area (cm2). Significance level of 5% is adopted for the analysis.<br>